One-on-one with pharmacists gives patients medication advantage

COLUMBUS, Ohio - After spending nearly an hour talking one-on-one with a pharmacist, participants in a new study reported using fewer medications and having far fewer drug-related problems.

Instead of having the subjects come to a pharmacy, the pharmacists came to the participants' churches.

Holding the one-on-one discussions at churches allowed people to come to an "emotionally safe, familiar and private environment, instead of the sometimes chaotic setting of a doctor's office or pharmacy," said Gerald Cable, a study co-author and a clinical assistant professor of pharmacy at Ohio State University.

"We weren't surprised at the extent of correctable medication problems we found," he said. "However, we were surprised that the participants were so willing to talk with us about these problems." More than half of the participants had kept medication past its expiration date, and nearly half reported that they had experienced adverse drug reactions.

But the intervention sessions seemed to help, as subjects reported using less medication during the six months after the one-on-one meeting than in the six months prior to the session.

"We hope that's a reflection of increased communication between the study participants an

Contact: Gerald Cable
Ohio State University

Page: 1 2 3 4 5

Related medicine news :

1. UNC study uncovers increasing shortage of pharmacists with growing population
2. Specialist care gives better rate of survival
3. Breakthrough in medical research: New chemotherapy gives hope to brain tumour patients
4. Kinder, gentler procedure gives superior results for stem cell transplants
5. Marine snail study gives insights into human brain
6. Mouse model gives insight to human hair loss
7. CT with multiplanar reconstruction gives new perspective on complex ankle fractures
8. ESA gives green light to funding for GMES
9. How brain gives special resonance to emotional memories
10. Off-label use of migraine drug gives children relief, study says
11. Study gives lowdown on high-temperature superconductivity

Post Your Comments:

(Date:11/27/2015)... ... ... the No.1 Herpes-only dating community in the world, revealed that over 50% of its members ... billion people under the age of 50 – or 67% of the population - are ... of HSV-1 infection . , "The data shocks us highly!" said Michelle Li, Co-Founder ...
(Date:11/27/2015)... ... 27, 2015 , ... Keeping in mind challenges faced by ... wellness consultation, has collaborated with a leading web-based marketplace for extra-curricular activities for ... parents and bring advice from parenting experts within their reach. As a part ...
(Date:11/27/2015)... ... November 27, 2015 , ... Indosoft ... announces the incorporation of Asterisk 11 LTS (Long Term Support) into its Q-Suite ... LTS brings Q-Suite 5.10 up-to-date with a version of Asterisk that will receive ...
(Date:11/26/2015)... ... November 26, 2015 , ... The ... bioavailability and the need to integrate dose form selection in early phase drug ... the membership organization supporting and bringing together the UK’s emerging life sciences companies, ...
(Date:11/26/2015)... ... November 26, 2015 , ... Health-E-minds ... collaborated with Women’s Web – an online resource for Indian women looking ... and emotional well-being relationship, life balance, stress, professional development, and lifestyle. Health-E-minds ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... DUBLIN , November 26, 2015 /PRNewswire/ ... the addition of the "Radioimmunoassay Market ... User (Hospital, Pharmaceutical Industry, Academics, Clinical Diagnostic ... - Global Forecast to 2020" report ... ) has announced the addition of the ...
(Date:11/25/2015)... DUBLIN , Nov. 25, 2015 /PRNewswire/ ... announced the addition of the "Global ... to their offering. --> http://www.researchandmarkets.com/research/rjc5xx/global_brain ... "Global Brain Monitoring Devices Market 2015-2019" ... Research and Markets ( http://www.researchandmarkets.com/research/rjc5xx/global_brain ) ...
(Date:11/25/2015)... OAKS, Calif. , Nov. 25, 2015  Amgen ... a Biologics License Application (BLA) with the ... (FDA) for ABP 501, a biosimilar candidate to Humira ... first adalimumab biosimilar application submitted to the FDA and ... pathway. Sean E. Harper , M.D., executive ...
Breaking Medicine Technology:
Cached News: